advertisement

Topcon

Li Y 11

Showing records 1 to 11 | Display all abstracts from Li Y

84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Sun C
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Zheng M
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Zhang H
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Zheng Y; Gao M
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Jiang J; Li Y
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Ma H; Zhang X
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Nie C; Gu J
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Li Y; Wang F
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Luo L
International Ophthalmology 2020; 40: 467-475
85069 Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
Huang H
Experimental and therapeutic medicine 2020; 19: 1329-1335
84677 Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy
Wang Z
International Ophthalmology 2020; 40: 467-475

Issue 21-1

Change Issue


advertisement

Oculus